2-Butoxy-3-Methylaniline
|
- $110 - $677
- Product name: 2-Butoxy-3-Methylaniline
- CAS: 1375068-69-1
- MF: C11H17NO
- MW: 179.26
- EINECS:
- MDL Number:MFCD22205731
- Synonyms:2-Butoxy-3-Methylaniline;Benzenamine, 2-butoxy-3-methyl-
6 prices
Selected condition：
Brand
- AK Scientific
- Apolloscientific
- Crysdot
- TRC
Package
- 500mg
- 1g
- 5g
- 10g
- 25g
- ManufacturerAK Scientific
- Product numberV2729
- Product description2-Butoxy-3-methylaniline
- Packaging1g
- Price$157
- Updated2021-12-16
- Buy
- ManufacturerApolloscientific
- Product numberOR911556
- Product description2-Butoxy-3-methylaniline 97%
- Packaging1g
- Price$167
- Updated2021-12-16
- Buy
- ManufacturerApolloscientific
- Product numberOR911556
- Product description2-Butoxy-3-methylaniline 97%
- Packaging5g
- Price$435
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12147618
- Product description2-Butoxy-3-methylaniline 95+%
- Packaging25g
- Price$677
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12147618
- Product description2-Butoxy-3-methylaniline 95+%
- Packaging10g
- Price$377
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberB701510
- Product description2-Butoxy-3-methylaniline
- Packaging500mg
- Price$110
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | V2729 | 2-Butoxy-3-methylaniline | 1g | $157 | 2021-12-16 | Buy |
| Apolloscientific | OR911556 | 2-Butoxy-3-methylaniline 97% | 1g | $167 | 2021-12-16 | Buy |
| Apolloscientific | OR911556 | 2-Butoxy-3-methylaniline 97% | 5g | $435 | 2021-12-16 | Buy |
| Crysdot | CD12147618 | 2-Butoxy-3-methylaniline 95+% | 25g | $677 | 2021-12-16 | Buy |
| Crysdot | CD12147618 | 2-Butoxy-3-methylaniline 95+% | 10g | $377 | 2021-12-16 | Buy |
| TRC | B701510 | 2-Butoxy-3-methylaniline | 500mg | $110 | 2021-12-16 | Buy |
Properties
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|